Capecitabine dosing is not yet optimized for breast cancer Journal Article

  

Authors:	Hudis, C.; Traina, T.; Norton, L.
Article Title:	Capecitabine dosing is not yet optimized for breast cancer
Keywords:	clinical trial; bevacizumab; doxorubicin; fluorouracil; drug safety; clinical trials as topic; capecitabine; adjuvant therapy; methotrexate; letter; metastasis; breast cancer; antimetabolites, antineoplastic; cyclophosphamide; dose-response relationship, drug; breast neoplasms; clinical research; drug dose regimen; deoxycytidine; lapatinib; prodrugs
Journal Title:	Annals of Oncology
Volume:	21
Issue:	11
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2010-11-01
Start Page:	2291
Language:	English
DOI:	10.1093/annonc/mdq264
PUBMED:	20501505
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-77958498240&partnerID=40&md5=cfaecf848f94b41ab786eeea94fd2e52
Notes:	--- - "Export Date: 20 April 2011" - "CODEN: ANONE" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/4280